Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 3,500 | 0 | 0 | 0 | 0 |
| Gross Profit | 3,500 | N/A | N/A | N/A | N/A |
| Operating Expenses | 77,716 | 79,514 | 77,906 | 56,355 | 49,678 |
| Operating Income | -74,216 | -79,514 | -77,906 | -56,355 | -49,678 |
| Interest Expense | 45 | 55 | 63 | 70 | 35 |
| Other Income | 6,198 | 7,169 | 5,496 | 5,279 | 5,098 |
| Pre-tax Income | -68,063 | -72,400 | -72,473 | -51,146 | -44,615 |
| Net Income Continuous | -68,063 | -72,400 | -72,473 | -51,146 | -44,615 |
| Net Income | $-68,063 | $-72,400 | $-72,473 | $-51,146 | $-44,615 |
| EPS Basic Total Ops | -0.80 | -0.85 | -1.02 | -0.73 | -0.64 |
| EPS Basic Continuous Ops | -0.80 | -0.85 | -1.01 | -0.73 | -0.64 |
| EPS Diluted Total Ops | -0.80 | -0.85 | -1.02 | -0.73 | -0.64 |
| EPS Diluted Continuous Ops | -0.80 | -0.85 | -1.01 | -0.73 | -0.64 |
| EPS Diluted Before Non-Recurring Items | -0.80 | -0.85 | -1.00 | N/A | N/A |
| EBITDA(a) | $-77,862 | $-83,332 | $-81,362 | $-60,011 | $-53,393 |